ESR1 and breast carcinoma: For example, tamoxifen and raloxifene, the classic drugs for clinical treatment of breast cancer, are ERα antagonists whereas BSC-pyrazole and MPP can fully antagonize E2 stimulation of pS2 mRNA in MCF-7 breast cancer cells.